Koers XsunX Inc OTC Bulletin Board
Aandelen
US98385L1026
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,17 mln. 2,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -926K | Nettowinst (verlies) 2023 | -4 mln. -3,7 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,41 mln. 1,31 mln. | Nettoschuld 2023 | 2,36 mln. 2,18 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,16
x | K/w-verhouding 2023 |
-0,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 59,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 10-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 18-03-22 |
John Cassarini
CHM | Chairman | 57 | 14-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |